Federal Court Certifies Class of Direct Purchasers in Antitrust Action Regarding ADHD Drug Intuniv

Judge Allison D. Burroughs of the United States District Court for the District of Massachusetts recently certified a class of direct purchasers of the ADHD drug Intuniv or its generic equivalent in an antitrust “pay-for-delay” case.  In re Intuniv Antitrust Litig., 16-cv-12653-ADB (D. Mass. Sept. 24, 2019), ECF No. 343.  Pay-for-delay arises during the course of patent litigation settlement, when a brand pharmaceutical company pays off a generic pharmaceutical company to give up the patent fight.  This removes the risk of the patent(s) covering a brand drug being invalidated, and can thereby postpone launches of less expensive generic drugs.  These are called “reverse payments” because they flow from the brand pharmaceutical company (the plaintiff) to the generic pharmaceutical company (the defendant).  Typically, a defendant pays a plaintiff to settle litigation. 

The direct purchasers allege that the brand manufacturer for Intuniv, Shire (now part of Takeda), settled with generic manufacturer Actavis by guaranteeing that when Actavis launched its generic version of Intuniv it would be the only generic on the market for six months.  Such arrangements limit competition and can constitute reverse payments under the antitrust laws because they allow the generic manufacturer to make more money during the exclusive six month period than it otherwise would have in a competitive market.  Absent this payment, the direct purchasers allege that less expensive generic versions of Intuniv would have come to market earlier. 

Judge Burroughs found that the class of direct purchasers, comprised of at least forty-eight entities, was sufficiently large that a class action would be the most practicable way to try the case.  Judge Burroughs also found that the class members’ claims all arise from the same allegedly anticompetitive conduct of the defendants, further demonstrating why a class action is warranted. 

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour, personal injury and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Delaware, Georgia and Pennsylvania.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About David Calvello

David Calvello is an Associate in Faruqi & Faruqi, LLP's New York office. He mainly practices in the area of antitrust litigation with a focus on competition in the pharmaceutical industry. He has worked on multiple cases that resulted in significant settlements, including In re Lidoderm Antitrust Litigation, 14-md-02521 (N.D. Cal.) ($166M settlement) and In re Solodyn Antitrust Litigation, 14-md-02503 (D. Mass.) ($76M settlement).

Tags: faruqi & faruqi, Actavis, Pay-for-Delay, faruqilaw, Antitrust, Intuniv, ADHD, Takeda, Shire, generics David Calvello David Calvello
Senior Associate at Faruqi & Faruqi, LLP

New York office
Tel: (212) 983-9330
Fax: (212) 983-9331
E-mail: dcalvello@faruqilaw.com

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania